Recommended Topic Related To:

Next Choice

"The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva Women's Health, Inc. to market Plan B One-Step (active ingredient levonorgestrel) for use without a prescription by women 15 years"...

Next Choice

font size

Next Choice™
(levonorgestrel) Tablets, 0.75 mg, for oral use

DRUG DESCRIPTION

Each Next Choice™ tablet contains 0.75 mg of a single active steroid ingredient, levonorgestrel [18,19-Dinorpregn-4-en-20-yn-3-one-13-ethyl-17-hydroxy-, (17α)-(-)-], a totally synthetic progestogen. The inactive ingredients present are colloidal silicon dioxide, corn starch, FD&C Yellow #6, magnesium stearate, povidone, and lactose monohydrate. Levonorgestrel has a molecular weight of 312.45, and the following structural and molecular formulas:

Next Choice™
(levonorgestrel) Structural Formula Illustration

Last reviewed on RxList: 7/19/2011
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.

Please acknowledge your agreement

Related Drugs

advertisement
advertisement
Use Pill Finder Find it Now

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies
Search the Medical Dictionary for Health Definitions & Medical Abbreviations